Reviews in Endocrine & Metabolic Disorders

Papers
(The TQCC of Reviews in Endocrine & Metabolic Disorders is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review184
Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality156
Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus144
Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review110
Traumatic brain injury and prolactin98
Epigenetic programming for obesity and noncommunicable disease: From womb to tomb85
New drugs for the treatment of obesity: do we need approaches to preserve muscle mass?78
Diagnostic and prognostic utility of phase angle in patients with cancer74
The genetics of Graves’ disease65
Endocrine responses of the stress system to different types of exercise55
Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review55
Posttranslational modifications in diabetes: Mechanisms and functions54
Prolactin deficiency in the context of other pituitary hormone abnormalities48
Preface44
Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients43
Androgens, aging, and prostate health41
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond41
Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic41
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease40
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease40
A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence39
No longer to be ignored: Hypophosphatemia following intravenous iron administration39
Hypothalamic GHRH36
Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis36
Mention to Prof. Andrew V. Schally36
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries35
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review35
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy34
Appetitive interoception, the hippocampus and western-style diet34
Deep neural network for food image classification and nutrient identification: A systematic review33
Ciliopathies are responsible for short stature and insulin resistance: A systematic review of this clinical association regarding SOFT syndrome33
Correction: Hypothalamic GHRH33
Therapeutic potentials of agonist and antagonist of adenosine receptors in type 2 diabetes32
Towards precision medicine in non-alcoholic fatty liver disease32
The bidirectional relationship of thyroid disease and atrial fibrillation: Established knowledge and future considerations30
Diagnostic accuracy of bilateral inferior petrosal sinus sampling using desmopressin or corticotropic- releasing hormone in ACTH-dependent Cushing’s syndrome: A systematic review and meta-analysis30
The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities30
Real-world evidence of effectiveness and safety of pasireotide in the treatment of acromegaly: a systematic review and meta-analysis29
Novel treatments for congenital adrenal hyperplasia29
Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review28
Computational approaches to predicting treatment response to obesity using neuroimaging28
Uterine fibroids in women diagnosed with acromegaly: a systematic review28
Regulation of adipogenesis by exosomal milk miRNA27
Correction to: Chemotherapy in NEN: still has a role?26
Malnutrition management of hospitalized patients with diabetes/hyperglycemia and COVID-19 infection26
Rathke’s cleft cyst: From history to molecular genetics26
Vitamin D, infections and immunity26
Food cue reactivity: Neurobiological and behavioral underpinnings26
GHRH in diabetes and metabolism25
Hidden chronic metabolic acidosis of diabetes type 2 (CMAD): Clues, causes and consequences25
Fluorescence-guided detection of pituitary neuroendocrine tumor (PitNET) tissue during endoscopic transsphenoidal surgery available agents, their potential, and technical aspects25
Diagnosing and treating anterior pituitary hormone deficiency in pediatric patients25
Prolactin: structure, receptors, and functions24
The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies24
Hypoprolactinemia, a neglected endocrine disorder24
Molecular testing for thyroid nodules: Where are we now?24
ATP-consuming futile cycles as energy dissipating mechanisms to counteract obesity24
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity23
The emerging role of transcription factor FOXP3 in thyroid cancer23
Gut-brain mechanisms underlying changes in disordered eating behaviour after bariatric surgery: a review23
Phase angle as an index of physiological status: validating bioelectrical assessments of hydration and cell mass in health and disease22
Endogenous Cushing’s syndrome during pregnancy22
Phase angle in applications of bioimpedance in health and disease22
Repurposing sodium-glucose co-transporter 2 inhibitors (SGLT2i) for cancer treatment – A Review22
Phase angle and COVID-19: A systematic review with meta-analysis21
Phase angle in localized bioimpedance measurements to assess and monitor muscle injury21
Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities21
Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications21
Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directions20
Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management20
A systematic review of resting-state functional connectivity in obesity: Refining current neurobiological frameworks and methodological considerations moving forward20
Contribution of the microbiome for better phenotyping of people living with obesity20
Nutritional status and gastroenteropancreatic neuroendocrine neoplasms: lights and shadows with a clinical guide from the NIKE Group20
Reference intervals for serum prolactin concentrations: analytical and clinical considerations20
Inborn errors of metabolism: Lessons from iPSC models19
Surgical outcomes of partial adrenalectomy for pheochromocytoma: A systematic review and meta-analysis19
Efficacy of radiofrequency and laser thermal ablation in solving thyroid nodule-related symptoms and cosmetic concerns. A systematic review and meta-analysis19
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes19
0.055006980895996